Cargando…
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
OBJECTIVE: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). MATERIALS AND METHODS: A total of 285 chronic ITP patients (187 women, 65.6%; 98 men, 34.4%) followed in 55...
Ejemplares similares
-
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data
por: Tombak, Anıl, et al.
Publicado: (2021) -
AB0 blood types: impact on development of prosthetic mechanical valve thrombosis
por: Astarcıoğlu, Mehmet Ali, et al.
Publicado: (2016) -
The role of protein Z and protein Z-dependent protease inhibitor polymorphisms in the development of prosthetic heart valve thrombosis
por: Karakoyun, Süleyman, et al.
Publicado: (2016) -
Presentation and Management of Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Experience
por: Dal, Mehmet Sinan, et al.
Publicado: (2016) -
The Role of Interleukin-6 and Interleukin-8 Gene Polymorphisms in Non-Alcoholic Steatohepatitis
por: Cengiz, Mustafa, et al.
Publicado: (2014)